Zhejiang Conba Pharmaceutical Co., Ltd. (600572) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Conba Pharmaceutical Co., Ltd.

Why is Zhejiang Conba Pharmaceutical Co., Ltd. ?

With ROE of 8.17%, it has a very attractive valuation with a 1.62 Price to Book Value

Over the past year, while the stock has generated a return of 0.68%, its profits have fallen by -6.9%
At the current price, the company has a high dividend yield of 3.5

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Zhejiang Conba Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Conba Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Zhejiang Conba Pharmaceutical Co., Ltd.

-10.69%

-1.12

16.65%

China Shanghai Composite

21.43%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

2.97%

EBIT Growth (5y)

1.76%

EBIT to Interest (avg)

16.39

Debt to EBITDA (avg)

0.22

Net Debt to Equity (avg)

-0.04

Sales to Capital Employed (avg)

0.85

Tax Ratio

17.09%

Dividend Payout Ratio

80.13%

Pledged Shares

Institutional Holding

ROCE (avg)

8.79%

ROE (avg)

15.16%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.43

EV to EBIT

19.44

EV to EBITDA

12.76

EV to Capital Employed

1.46

EV to Sales

1.47

PEG Ratio

Dividend Yield

3.72%

ROCE (Latest)

7.51%

ROE (Latest)

6.70%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bullish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 1,048.17 MM

INTEREST COVERAGE RATIO(Q)

Highest at 16,185.64

RAW MATERIAL COST(Y)

Fallen by -7.56% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.78 times

DEBTORS TURNOVER RATIO(HY)

Highest at 3.43 times

NET SALES(Q)

Highest at CNY 1,905.51 MM

PRE-TAX PROFIT(Q)

Highest at CNY 256.99 MM

NET PROFIT(Q)

Highest at CNY 214.44 MM

-5What is not working for the Company

NET PROFIT(HY)

At CNY 155.54 MM has Grown at -42.79%

ROCE(HY)

Lowest at 6.77%

Here's what is working for Zhejiang Conba Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 1,048.17 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Interest Coverage Ratio

Highest at 16,185.64

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales

Highest at CNY 1,905.51 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 1,905.51 MM has Grown at 17.74%

over average net sales of the previous four periods of CNY 1,618.36 MM

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 256.99 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 256.99 MM has Grown at 104.46%

over average net sales of the previous four periods of CNY 125.69 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 214.44 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY 214.44 MM has Grown at 100.88%

over average net sales of the previous four periods of CNY 106.75 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Inventory Turnover Ratio

Highest at 2.78 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 3.43 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -7.56% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales